Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Blueberries Medical Corp C.BBM

Alternate Symbol(s):  BBRRF

Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. Its operations are mainly focused on the Bogota Savannah, in central Colombia. The Company is focused on... see more

CSE:BBM - Post Discussion

Blueberries Medical Corp > Patience until GMP approval
View:
Post by phoenix_trader on Dec 10, 2020 11:46am

Patience until GMP approval

Both Clever Leaves (Market Cap US$150 mill) and Khiron (MC Cdn$57 mill) are now exporting CBD and burning through cash monthly.

Blueberries (MC Cdn$8 mill) is months away from similar exports and maintaining cash.


Anyone know the extract capacity of Clever Leaves and Khiron?
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities